Clinical Trial Update: Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on the PXL Platinum 330 System with riboflavin for corneal ulcers, involving Phase 2 and Phase 3, evaluating safety and effectiveness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ulcer
• Keratitis

Drugs mentioned

• PXL Platinum 330 System
• Riboflavin solution (Riboflavin)

Snippet

Sponsor: Peschke GmbH | Conditions: Keratitis, Corneal Ulcer | Phase 2, Phase 3 | Status: UNKNOWN